Humacyte Inc

NEW
NAS:HUMA (USA)  
$ 5.06 -0.1 (-1.94%) 07:09 PM EST
At Loss
Market Cap:
$ 632.89M
Enterprise V:
$ 569.78M
Volume:
3.34M
Avg Vol (2M):
2.89M
Trade In:
Volume:
3.34M
At Loss
Avg Vol (2M):
2.89M

Business Description

Description
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Name Current Vs Industry Vs History
Cash-To-Debt 5.22
Equity-to-Asset -0.21
Debt-to-Equity -0.63
Debt-to-EBITDA -0.14
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.99
9-Day RSI 40.24
14-Day RSI 43.04
6-1 Month Momentum % 38.78
12-1 Month Momentum % 156.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.41
Quick Ratio 5.41
Cash Ratio 5.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2
Shareholder Yield % -2.98
Name Current Vs Industry Vs History
ROE % -637.59
ROA % -93.67
ROIC % -205.96
3-Year ROIIC % 181.49
ROC (Joel Greenblatt) % -297.29
ROCE % -98.81

Financials (Next Earnings Date:2024-11-08 Est.)

HUMA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:HUMA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Humacyte Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.26
Beta 1.39
Volatility % 156.71
14-Day RSI 43.04
14-Day ATR ($) 0.441354
20-Day SMA ($) 5.46725
12-1 Month Momentum % 156.6
52-Week Range ($) 2.02 - 9.97
Shares Outstanding (Mil) 125.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Humacyte Inc Filings

Filing Date Document Date Form
No Filing Data

Humacyte Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Humacyte Inc Frequently Asked Questions

What is Humacyte Inc(HUMA)'s stock price today?
The current price of HUMA is $5.06. The 52 week high of HUMA is $9.97 and 52 week low is $2.02.
When is next earnings date of Humacyte Inc(HUMA)?
The next earnings date of Humacyte Inc(HUMA) is 2024-11-08 Est..
Does Humacyte Inc(HUMA) pay dividends? If so, how much?
Humacyte Inc(HUMA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1